Low-dose renin inhibitor and low-dose AT(1)-receptor blocker therapy ameliorate target-organ damage in rats harbouring human renin and angiotensinogen genes

Tools

Item Type:	Article
Title:	Low-dose renin inhibitor and low-dose AT(1)-receptor blocker therapy ameliorate target-organ damage in rats harbouring human renin and angiotensinogen genes
Creators Name:	Dechend, R., Shagdarsuren, E., Gratze, P., Fiebeler, A., Pilz, B., Meiners, S., Derer, W., Feldman, D.L., Webb, R. and Mueller, D.N.
Abstract:	We studied the effects of extremely low-dose human renin inhibition (aliskiren) with low angiotensin II receptor blockade (losartan) in a novel double-transgenic rat model harbouring both human renin and angiotensinogen genes. We found that low-dose aliskiren and low-dose losartan effectively reduced mortality and target-organ damage with minimal, non-significant, effects on blood pressure (BP). Our data suggest that renin-angiotensin system (RAS) inhibition ameliorates target-organ damage in an Ang II-driven model of hypertension. Direct renin inhibition is equally efficacious in this regard. Our study does not fully answer the question of BP-lowering versus RAS inhibition. This question is important and was at least partially addressed with our low-dose model.
Keywords:	Angiotensin II, Renin inhibitor, Inflammation, Albuminuria, Cardiac damage, Animals, Rats
Source:	Journal of the Renin Angiotensin Aldosterone System
ISSN:	1470-3203
Publisher:	JRAAS
Volume:	8
Number:	2
Page Range:	81-84
Date:	June 2007
Official Publication:	https://doi.org/10.3317/jraas.2007.008
PubMed:	View item in PubMed

Repository Staff Only: item control page